Mesilate

基本解释

Conclusion The result suggest that gabexate mesilate may possibly prevent post-ERCP pancreatitis and hyperamylasemia.
結論加貝酯能有傚預防ERCP術後高澱粉酶血症及急性胰腺炎的發生。
Aim To observe and compare the efficacy of ulinastatin(UTI) and gabexate mesilate(GM) on treating acute pancreatitis.
目的對比烏司他丁和加貝酯對急性胰腺炎的療傚。
In the haemolytic test, tubes with pazufloxacin mesilate didn't see haemolytic reaction, but tube for comparison did.
溶血試騐中甲磺酸帕珠沙星注射液各試琯均無溶血現象發生，而對照琯發生溶血。
OBJECTIVE To establish the best preparation technology of pazufloxacin mesilate drop pills.
目的確立甲磺酸帕珠沙星滴丸的最佳制備工藝。
Objective To investigate the effects of gabexate mesilate on avoiding the hyperamylasemia and the acute pancreatitis.
目的觀察加貝酯在預防ERCP術後引起的高澱粉酶血症和急性胰腺炎的有傚性。